New publication in Nature Genetics
We are very happy to see a new paper of the MESOMICS project published in Nature Genetics together with a Research Briefing explaining the importance of the findings. This has been a major team effort that we hope will soon translate in a better clinical management of patients with malignant pleural mesothelioma. See twittorial here
The RCG team welcomes two new members
Laurane Mangé is a Master student in Bioinformatics and Modelling from the National Institute of Applied Sciences of Lyon (INSA Lyon). She will be working for 6 months with Nicolas Alcala on the genomic evolution of tumor phenotypes and on single-cell transcriptomics of malignant pleural mesothelioma. Maike Morrison is a PhD student in Biology from
The RCG team marks Rare Disease Day 2023 with a new video
In a new video to mark Rare Disease Day, Matthieu Foll, Alexandra Sexton Ouates and Emilie Mathian from the RCG team at IARC present one aspect of the lungNENomics project, which aims to improve the diagnosis and clinical management of lung neuroendocrine tumours using a combination of AI and genomic techniques. Read the IARC press
The Lyon Integrated Cancer Research Site (LYriCAN+) has just been re-labeled by the French National Cancer Institute (INCa).
And the IARC-RCG team is very happy to have contributed to it with Lynnette Fernandez-Cuesta co-leading together with Sandra Ortiz-Cuaran one of the Work Packages in the Integrated Research Program entitled “characterization and treatment of tumor and immune cell plasticity in the clinic”
Neuroendocrine Tumor Research Foundation investigator award to Matthieu Foll
Scientists from the RCG team are among the recipients of research grants awarded by the Neuroendocrine Tumor Research Foundation (NETRF), announced on 16 February. Matthieu Foll, Lynnette Fernandez-Cuesta, and their co-investigators in the “Reconciling lung carcinoids histopathological and molecular classifications” project were chosen to receive the funding through a competitive and rigorous peer-review process. This
Oral presentation at the 18th edition of the International Conference on Theory and Applications of Computer Vision (Visapp 2023)
Emilie Mathian had an amazing time at the 18th edition of the International Conference on Theory and Applications of Computer Vision in Lisbon, Portugal (Visapp 2023). The conference was an opportunity to learn about theoretical and applicative advances in computer vision and robotics from the best researchers in the field. Emilie presented her paper entitled
The RCG team welcomes Dr. Gabrielle Drevet
Dr. Gabrielle Drevet is a thoracic surgeon at the Lyon university hospital centre (HCL – service de chirurgie thoracique videothoracoscopie et transplantation pulmonaire). She is starting a PhD co-supervised by Dr. Matthieu Foll and Dr. Jean Michel-Maury (HCL), exploring the molecular heterogeneity of pleural tumors.
Oral presentation at the 2022 NETRF Symposium
Matthieu Foll presented the advances of the lungNENomics project with an oral talk entitled “Characterising Aggressive Pulmonary Carcinoids Through Integrative Omics Analysis Within the lungNENomics Project” during the 2022 Neuroendocrine Tumor Research Foundation (NETRF) Symposium, Boston, USA (November 17-18). This work has been funded by a NETRF 2019 investigator award to Lynnette Fernandez-Cuesta.
Poster presentation at the 5th International Cancer Symposium of the Lyon Cancer Research Center
Dr. Alexandra Sexton and Emilie Mathian presented two posters at the 5th International Cancer Symposium of the Lyon Cancer Research Center (CRCL), on mesothelioma and neuroendocrine carcoids of the lung, respectively. Alexandra’s poster entitled « Disentangling heterogeneity of malignant pleural mesothelioma through deep integrative omics analyses », presents our paper of the same name recently accepted in
Invited keynote lecture at the 12th European Meeting on Molecular Diagnostics
Matthieu Foll was invited to give a keynote lecture at 12th European Meeting on Molecular Diagnostics, Noordwijk, Netherland (October 12-14) entitled “Multi-omics characterization of heterogeneous tumors”.